Cooperative Agreement U24DK123768

This $829,637 Project Grant awarded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to determine the effectiveness of real-time continuous glucose monitoring (CGM) at reducing maternal and neonatal morbidity and mortality in pregnant individuals with type 2 diabetes. The research will define adequate glycemic control targets for CGM and self-monitoring of blood glucose, and identify social...

The University of California, Davis has been awarded a $280,140 Cooperative Agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The purpose of this 5-year project is to conduct a longitudinal cohort study to characterize the associations between type 1 diabetes-related factors, such as diabetic ketoacidosis and glycemic control, and neurocognitive outcomes in...

This Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $277,540 to The Nemours Foundation to conduct a longitudinal observational study on the cognitive, structural, and functional impact of new-onset type 1 diabetes on the brains of young children aged 4-10 years. The study aims to assess neurocognitive function, correlate it...

This Cooperative Agreement award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $3,717,718 in funding to Duke University to conduct the U.S. portion of the multinational LEADER-PAD clinical trial. The trial will enroll 1,000 U.S. participants as part of a planned 6,150 participant international study to assess whether low-dose colchicine can reduce the risk of cardiovascular and limb-related outcomes in patients with peripheral artery...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a 5-year, $271,385 Cooperative Agreement (Award ID: U01DK140735) to the University of Colorado Denver under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The purpose of this award is to investigate the impact of type 1 diabetes (T1D) on neurocognitive and psychosocial functioning in pre-pubertal children. The research will examine the long-term effects of diabetic...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,220,496 Cooperative Agreement under the Cardiovascular Diseases Research (CFDA 93.837) program to Duke University to conduct the U.S. portion of the multinational LEADER-PAD clinical trial. The trial will enroll 1,000 U.S. participants out of a planned 6,150 participants globally to assess whether low-dose colchicine can reduce the risk of cardiovascular and limb-related outcomes in patients with peripheral artery disease...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,398,792 Cooperative Agreement under CFDA 93.837 Cardiovascular Diseases Research to Wake Forest University Health Sciences (WFUHS) on September 17, 2024. The funding will support WFUHS serving as the Data Coordinating Center (DCC) for the "Improving Mobility After Revascularization in Peripheral Artery Disease: The IMPACT PAD Trial" (IMPACT PAD), a 2x2 factorial randomized controlled trial with an enrollment target of...

This $1,008,750 Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to investigate the cellular and molecular dysfunctions in epicardial fat and coronary vasculature in type 1 diabetes (T1D). The project utilizes the CARE-T1D Consortium tissue bank to: Comprehensively identify T1D-specific cell states and regulators in epicardial fat and coronary...

This Cooperative Agreement award is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award provides $320,972 to Joslin Diabetes Center, Inc. and Boston Children's Hospital to evaluate the impact of type 1 diabetes (T1D) on brain development and neurocognitive functioning in a racially and ethnically diverse cohort of 600 pre-pubertal children with newly...

This is a Cooperative Agreement awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $270,932 award to the Trustees of Indiana University (IU Indianapolis) will fund a study to characterize the associations between cognitive function, brain structure, and clinical/environmental parameters in children with type 1 diabetes. The 5-year project aims to: 1) better...